| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Articles |
Airway pathology is increasingly considered to be a major outcome in asthma research. The aim of this study was to examine the intra-observer, within-section and between-biopsy repeatability, together with the implications for statistical power of a computerized quantitative analysis of inflammatory cell numbers in the lamina propria in bronchial biopsy specimens from atopic asthmatic subjects. Thirty six atopic adults (aged 19-40 yrs) with mild to moderate asthma (baseline forced expiratory volume in one second (FEV1) > or =50% of predicted value, methacholine (PC20) range 0.02-18.2 mg x mL[-1]) at various levels of treatment (25 subjects on inhaled steroids) entered the study. Biopsies were taken from the (sub)segmental carinae of the right lower and middle lobe and from the main carina. Specimens were snap-frozen and immunohistochemical staining was performed on cryostat sections with monoclonal antibodies against: (secreted) eosinophil cationic protein (EG1, EG2), mast cell tryptase (AA1), CD45, CD22, CD4, CD8, CD25, and CD45RO. Using a computerized system, the number of positively stained cells in the lamina propria was counted. When considering all cell types together, satisfactory intraclass correlation coefficients (ICC) values were obtained for intra-observer, within-section and between-biopsy repeatability, being 0.90, 0.80 and 0.81, respectively. The analysis of repeatability for individual cell types revealed ICC values ranging 0.47-0.82 for intra-observer, 0.44-0.76 for within-section and 0.37-0.67 for between-biopsy repeatability. The results imply that a sample-size between eight and 25 subjects is needed to detect at least one doubling difference in cell number per 0.1 mm2 for a particular inflammatory cell type in a study, using a within-group design with alpha=0.05 and power of 0.80. A sample-size of 13-48 subjects per group is required to detect the same difference between the groups in a parallel design.
This article has been cited by other articles:
|
|
 |
|
  M. L. Carroll, N. G. Carroll, and A. L. James Do bronchial biopsies represent mast cell density in airways? A stereological study Eur. Respir. J., September 1, 2006; 28(3): 612 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gamble, Y. Qiu, D. Wang, J. Zhu, A. M. Vignola{dagger}, C. Kroegel, F. Morell, T. T. Hansel, I. D. Pavord, K. F. Rabe, et al. Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design Eur. Respir. J., February 1, 2006; 27(2): 293 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. J. van Rensen, J. K. Sont, C. E. Evertse, L. N. A. Willems, T. Mauad, P. S. Hiemstra, P. J. Sterk, and the AMPUL Study Group Bronchial CD8 Cell Infiltrate and Lung Function Decline in Asthma Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 837 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Bourdin, I Serre, H Flamme, P Vic, D Neveu, P Aubas, P Godard, and P Chanez Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? Thorax, June 1, 2004; 59(6): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gamble, W. Burns, J. Zhu, T. Ansari, V. De Rose, J. Kips, N.C. Barnes, and P.K. Jeffery Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis Eur. Respir. J., December 1, 2003; 22(6): 992 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Wenzel, H. W. Chu, P. Silkoff, S. O'Sullivan, L. Poulter, M. Akveld, and C. M. Burke Ensuring Quality in Pharmaceutical Studies Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 1010 - 1012. [Full Text]
|
|
|
|
|
|
J. K. Sont, W. I. de Boer, W. A. A. M. van Schadewijk, K. Grunberg, J. H. J. M. van Krieken, P. S. Hiemstra, and P. J. Sterk Fully Automated Assessment of Inflammatory Cell Counts and Cytokine Expression in Bronchial Tissue Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1496 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. O'Sullivan, M. Akveld, C. M. Burke, and L. W. Poulter Effect of the Addition of Montelukast to Inhaled Fluticasone Propionate on Airway Inflammation Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 745 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. de Kluijver, K. Grunberg, J.K. Sont, M. Hoogeveen, W.A.A.M. van Schadewijk, E.P.A. de Klerk, C.R. Dick, J.H.J.M. van Krieken, and P.J. Sterk Rhinovirus infection in nonasthmatic subjects: effects on intrapulmonary airways Eur. Respir. J., August 1, 2002; 20(2): 274 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. FAUL, E. A. DEMERS, C. M. BURKE, and L. W. POULTER The Reproducibility of Repeat Measures of Airway Inflammation in Stable Atopic Asthma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1457 - 1461. [Abstract] [Full Text]
|
|
|
|
|
|
J. K. SONT, L. N. A. WILLEMS, E. H. BEL, J.H. J. M. van KRIEKEN, J. P. VANDENBROUCKE, P. J. STERK, and the AMPUL Study Group Clinical Control and Histopathologic Outcome of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term Treatment Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1043 - 1051. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
